TT TriVascular Technologies, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Source id SEC:trivascular-technologies-inc-040ce9 US · SEC (Form 4) Mcap US$2.2B Track the TriVascular Technologies, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 5 February 2016 (U). Among the most active insiders: Jayaraman Vivek K. All data is free.
Analyst consensus: bullish or bearish? Analysts rate TriVascular Technologies, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 February 2016
All Executives53 Thresholds0 Prospectus0 Other0
Declarations 53 total
● 10% Owner · Executives · 3 Feb 2016
3,535,910 shares Common Stock SEC:0001209191-16-095921:0
● Director · Executives · 3 Feb 2016
149 shares Common Stock SEC:0001209191-16-095922:0
● Director · Executives · 3 Feb 2016
3,535,910 shares Common Stock SEC:0001209191-16-095922:1
● VP Global Sales and Marketing · Executives · 3 Feb 2016
27,081 shares Common Stock SEC:0001562180-16-001517:5
● 10% Owner · Executives · 3 Feb 2016
3,943,269 shares Common Stock SEC:0001209191-16-095748:0
◇ President, CEO and Chairman · Executives · 3 Feb 2016
83,603 shares Common Stock SEC:0001562180-16-001511:0
● President, CEO and Chairman · Executives · 3 Feb 2016
23,435 shares Common Stock SEC:0001562180-16-001511:1
● President, CEO and Chairman · Executives · 3 Feb 2016
60,168 shares Common Stock SEC:0001562180-16-001511:2
◇ President, CEO and Chairman · Executives · 3 Feb 2016
29,720 shares Common Stock SEC:0001562180-16-001511:3
● President, CEO and Chairman · Executives · 3 Feb 2016
21,279 shares Common Stock SEC:0001562180-16-001511:4
● President, CEO and Chairman · Executives · 3 Feb 2016
8,441 shares Common Stock SEC:0001562180-16-001511:5
● President, CEO and Chairman · Executives · 3 Feb 2016
659,952 shares Common Stock SEC:0001562180-16-001511:6
◇ Chief Technology Officer · Executives · 3 Feb 2016
12,400 shares Common Stock SEC:0001562180-16-001513:0
● Chief Technology Officer · Executives · 3 Feb 2016
5,429 shares Common Stock SEC:0001562180-16-001513:1
● Chief Technology Officer · Executives · 3 Feb 2016
6,971 shares Common Stock SEC:0001562180-16-001513:2
◇ Chief Technology Officer · Executives · 3 Feb 2016
22,137 shares Common Stock SEC:0001562180-16-001513:3
● Chief Technology Officer · Executives · 3 Feb 2016
15,073 shares Common Stock SEC:0001562180-16-001513:4
● Chief Technology Officer · Executives · 3 Feb 2016
7,064 shares Common Stock SEC:0001562180-16-001513:5
● Chief Technology Officer · Executives · 3 Feb 2016
174,087 shares Common Stock SEC:0001562180-16-001513:6
● VP, Gen. Counsel and Secretary · Executives · 3 Feb 2016
4,898 shares Common Stock SEC:0001562180-16-001515:1
● VP, Gen. Counsel and Secretary · Executives · 3 Feb 2016
10,102 shares Common Stock SEC:0001562180-16-001515:2
◇ VP, Gen. Counsel and Secretary · Executives · 3 Feb 2016
61,621 shares Common Stock SEC:0001562180-16-001515:3
● VP, Gen. Counsel and Secretary · Executives · 3 Feb 2016
35,635 shares Common Stock SEC:0001562180-16-001515:4
● VP, Gen. Counsel and Secretary · Executives · 3 Feb 2016
25,986 shares Common Stock SEC:0001562180-16-001515:5
● VP, Gen. Counsel and Secretary · Executives · 3 Feb 2016
4,119 shares Common Stock SEC:0001562180-16-001515:6
25 of 53 declarations
Load more (28 remaining) Acerca de TriVascular Technologies, Inc. TriVascular Technologies, Inc. es una empresa centrada en el desarrollo de dispositivos médicos para el tratamiento de enfermedades vasculares. Cotiza en el mercado XNAS.